Drug major Sun Pharmaceutical Industries on Friday reported a consolidated net loss of ₹1,655.60 crore for the quarter ended June 30, 2020. The company had posted a net profit of ₹1,387.48 crore for the corresponding period of the previous fiscal.
The company’s consolidated revenue from operations stood at ₹7,585.25 crore for the quarter as against ₹8,374.36 crore for the same period year ago.
Shares of Sun Pharmaceutical Industries closed at ₹531.75 on the BSE, up 4.27 per cent over previous close.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.